<DOC>
	<DOCNO>NCT00019461</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness carboxyamidotriazole treat patient refractory recurrent ovarian epithelial , fallopian tube , primary peritoneal cancer .</brief_summary>
	<brief_title>Carboxyamidotriazole Treating Patients With Refractory Recurrent Ovarian Epithelial , Fallopian Tube , Primary Peritoneal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine clinical outcome patient ovarian epithelial , fallopian tube , primary peritoneal cancer treat carboxyamidotriazole . OUTLINE : Patients receive oral carboxyamidotriazole daily begin day 1 . Treatment continue absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 19-40 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Carboxyamido-triazole</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm refractory recurrent ovarian epithelial , fallopian tube , primary peritoneal cancer Measurable disease physical exam , radiography , peritoneoscopy , laparoscopy No 4 week since prior peritoneoscopy No brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 4 month Hematopoietic : Absolute neutrophil count least 1,000/mm^3 Platelet count least 100,000/mm^3 Hemoglobin least 9.0 g/dL AND/OR Hematocrit least 27 % Hepatic : SGOT/SGPT great 3 time upper limit normal Bilirubin normal Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 50 mL/min Cardiovascular : No history symptomatic cardiac dysrhythmias require medication At least 6 month since prior myocardial infarction No unstable newly diagnose angina Pulmonary : No obstructive lung disease require oxygen therapy Other : Not pregnant nursing HIV negative Must able take oral medication No concurrent medical condition ( e.g. , impend bowel obstruction ) No grade 2 great residual peripheral neuropathy No active infection No prior concurrent invasive malignancy within past 5 year No history acute visual loss associate retinal detachment PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior cytokine therapy No concurrent cytokine therapy maintain WBC count Chemotherapy : At least 4 week since prior chemotherapy ( 6 week nitrosoureas , carboplatin , mitomycin ) No concurrent chemotherapy Endocrine therapy : At least 4 week since prior hormonal therapy No concurrent corticosteroid dose great physiological replacement dose No concurrent hormonal therapy Radiotherapy : At least 4 week since prior radiotherapy No concurrent radiotherapy Surgery : See Disease Characteristics Other : No 3 prior treatment regimen At least 1 week since prior systemic antibiotic infection No chronic antifungal treatment antimycotic imidazoles No concurrent alternative therapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2003</verification_date>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>fallopian tube cancer</keyword>
	<keyword>primary peritoneal cavity cancer</keyword>
</DOC>